Highlights Mankind Pharma Limited

Equities

MANKIND

INE634S01028

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 05:19:42 11/07/2025 pm IST			5-day change	1st Jan Change
2,578.30 ^INR	+1.35%		+5.69%	-10.49%

11/07	Jefferies Adjusts Mankind Pharma's Price Target to INR3,000 From INR2,870, Keeps at Buy	MT
30/06	India's Torrent Pharma to acquire controlling stake in JB Chem and Pharma	RE

Highlights

India's Torrent Pharma to acquire controlling stake in JB Chem and Pharma	30/06	RE
Mankind Pharma Incorporates Not-for-Profit Subsidiary	03/06	MT
Maneane Pharma Limited Announces Intimation of Incorporation of A Wholly Owned Subsidiary Company	02/06	CI
Mankind Pharma to Incorporate Wholly Owned Subsidiary in Sri Lanka	22/05	MT
India's Mankind Pharma beats profit estimates on demand for drugs to treat chronic illnesses	21/05	RE
Mankind Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2025	21/05	CI
Mankind Pharma Q4 Consol Net Profit 4.21 Billion Rupees IBES Est. 3.60 Billion Rupees	21/05	RE
Mankind Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025	21/05	CI
Mankind Pharma Gets Board Nod to Form Two Subsidiaries	15/04	MT
Mankind Pharma Limited Announces Incorporation of Wholly Owned Subsidiary, Directly or Indirectly, in Russia and Wholly Owned Subsidiary Under Section 8 of the Companies Act, 2013	14/04	CI
Mankind Pharma Finalizes Sale of Mahananda Spa and Resorts	12/02	MT
Chalet Hotels Gets Board Nod to Acquire Mahananda Spa and Resorts	11/02	MT
Chalet Hotels Limited completed the acquisition of Mahananda Spa And Resorts Private Limited from Mankind Pharma Limited.	11/02	CI
Chalet Hotels Limited signed a letter of intent to acquire Mahananda Spa And Resorts Private Limited from Mankind Pharma Limited for an enterprise value of INR 5.3 billion.	10/02	CI
Jefferies Adjusts Mankind Pharma's Price Target to INR3,300 From INR3,370, Keeps at Buy	27/01	MT
Mankind Pharma Posts Decline in Fiscal Q3 Consolidated Net Profit	24/01	MT
India's Mankind Pharma misses Q3 profit view as expenses jump	23/01	RE
Mankind Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	23/01	CI
Mankind Pharma Limited Announces Executive Changes	08/01	CI
Mankind Pharma Limited Receives Order from Office of the Assistant Commissioner, CGST, Meerut	28/12	CI
Mankind Pharma Limited Approves Appointment of Ashish Mittal as Company Secretary and Compliance Officer	03/12	CI
Jefferies Adjusts Mankind Pharma's Price Target to INR3,200 From INR2,430, Keeps at Buy	06/11	MT
Mankind Pharma's Consolidated Net Profit Rises in Fiscal Q2	06/11	MT
India's Mankind Pharma tops Q2 profit view on higher demand for chronic drugs	05/11	RE
Mankind Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	05/11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Mankind Pharma Limited

Equities

MANKIND

INE634S01028

Pharmaceuticals

Highlights

Filters